EPHB 4 Gene Polymorphisms and Risk of Intracranial Hemorrhage in Patients With Brain Arteriovenous Malformations

Background—Brain arteriovenous malformations (BAVMs) are a tangle of abnormal vessels directly shunting blood from the arterial to venous circulation and an important cause of intracranial hemorrhage (ICH). EphB4 is involved in arterial-venous determination during embryogenesis; altered signaling could lead to vascular instability resulting in ICH. We investigated the association of single-nucleotide polymorphisms (SNPs) and haplotypes in EPHB4 with risk of ICH at clinical presentation in patients with BAVM. Methods and Results—Eight haplotype-tagging SNPs spanning 29 kb were tested for association with ICH presentation in 146 white patients with BAVM (phase I: 56 ICH, 90 non-ICH) using allelic, haplotypic, and principal components analysis. Associated SNPs were then genotyped in 102 additional cases (phase II: 37 ICH, 65 non-ICH), and data were combined for multivariable logistic regression. Minor alleles of 2 SNPs were associated with reduced risk of ICH presentation (rs314313_C, P 0.005; rs314308_T, P 0.0004). Overall, haplotypes were also significantly associated with ICH presentation ( 2 17.24, 6 df, P 0.008); 2 haplotypes containing the rs314308 T allele (GCCTGGGT, P 0.003; GTCTGGGC, P 0.036) were associated with reduced risk. In principal components analysis, 2 components explained 91% of the variance and complemented haplotype results by implicating 4 SNPs at the 5 end, including rs314308 and rs314313. These 2 SNPs were replicated in the phase II cohort, and combined data resulted in greater significance (rs314313, P 0.0007; rs314308, P 0.00008). SNP association with ICH presentation persisted after adjusting for age, sex, BAVM size, and deep venous drainage. Conclusions—EPHB4 polymorphisms are associated with risk of ICH presentation in patients with BAVM, warranting further study. (Circ Cardiovasc Genet. 2009;2:476-482.)

[1]  H. Augustin,et al.  Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes , 2008, Journal of Cell Science.

[2]  Rong A. Wang,et al.  Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis , 2008, Development.

[3]  Shengshou Hu,et al.  Arterial–venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation , 2008, FEBS letters.

[4]  K. Lunetta.  Genetic Association Studies , 2008, Circulation.

[5]  N. Barbaro,et al.  EVIDENCE OF INFLAMMATORY CELL INVOLVEMENT IN BRAIN ARTERIOVENOUS MALFORMATIONS , 2008, Neurosurgery.

[6]  K. Giacomini,et al.  Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics , 2008, Clinical pharmacology and therapeutics.

[7]  Issam A Awad,et al.  CONCEPTS AND HYPOTHESES: INFLAMMATORY HYPOTHESIS IN THE PATHOGENESIS OF CEREBRAL CAVERNOUS MALFORMATIONS , 2007, Neurosurgery.

[8]  C. McCulloch,et al.  Racial/Ethnic Differences in Longitudinal Risk of Intracranial Hemorrhage in Brain Arteriovenous Malformation Patients , 2007, Stroke.

[9]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[10]  Gerard Tromp,et al.  Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms , 2007, BMC Genomics.

[11]  David V Conti,et al.  Testing association between disease and multiple SNPs in a candidate gene , 2007, Genetic epidemiology.

[12]  H. Drexler,et al.  Notch Ligand Delta-Like 1 Is Essential for Postnatal Arteriogenesis , 2007, Circulation research.

[13]  J. W. B. van der Sprenkel,et al.  Familial occurrence of brain arteriovenous malformations: a systematic review , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[14]  Alan M. Moses,et al.  In vivo enhancer analysis of human conserved non-coding sequences , 2006, Nature.

[15]  A. A. Romanovsky,et al.  Putative dual role of ephrin‐Eph receptor interactions in inflammation , 2006, IUBMB life.

[16]  Peter Libby,et al.  Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Santhosh K. P. Kumar,et al.  The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. , 2006, Blood.

[18]  Peter Vajkoczy,et al.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis , 2006, The EMBO journal.

[19]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[20]  J. Mohr,et al.  Brain arteriovenous malformations in adults , 2005, The Lancet Neurology.

[21]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[22]  C. McCulloch,et al.  Polymorphisms in Genes Involved in Inflammatory and Angiogenic Pathways and the Risk of Hemorrhagic Presentation of Brain Arteriovenous Malformations , 2004, Stroke.

[23]  H. Augustin,et al.  Inhibition of tumor growth and angiogenesis by soluble EphB4. , 2004, Neoplasia.

[24]  E. Pasquale,et al.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Weir,et al.  Properties of the Multiallelic Trend Test , 2004, Biometrics.

[26]  H. Dressman,et al.  Gene Microarray Analysis of Human Brain Arteriovenous Malformations , 2004, Neurosurgery.

[27]  Wen-Chung Lee,et al.  Searching for disease-susceptibility loci by testing for Hardy-Weinberg disequilibrium in a gene bank of affected individuals. , 2003, American journal of epidemiology.

[28]  Issam A Awad,et al.  Differential Gene Expression in Human Cerebrovascular Malformations , 2003, Neurosurgery.

[29]  R. Adams.  Molecular control of arterial–venous blood vessel identity , 2003, Journal of anatomy.

[30]  G. Yancopoulos,et al.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. , 2001, Developmental biology.

[31]  E. Pasquale,et al.  The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization , 2000, Oncogene.

[32]  D. Anderson,et al.  Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. , 1999, Molecular cell.

[33]  M. Taneda,et al.  Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. , 1999, Stroke.

[34]  F. Diella,et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.

[35]  A. Andres,et al.  Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. , 1998, Journal of cell science.

[36]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[37]  N. Risch,et al.  A comparison of linkage disequilibrium measures for fine-scale mapping. , 1995, Genomics.

[38]  Pui-Yan Kwok,et al.  Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. , 2006, Stroke.

[39]  T. M. Hsu,et al.  Homogeneous primer extension assay with fluorescence polarization detection. , 2003, Methods in molecular biology.

[40]  M. Dichgans,et al.  Section Editors: the Genetic Architecture of Intracerebral Hemorrhage , 2022 .